News

LigoCyte, Biogen Idec to jointly develop anti-inflammatory treatment

September 18, 2007/

LigoCyte Pharmaceuticals Inc http://www.ligocyte.com/ said it and biotechnology group Biogen Idec Inc http://www.biogenidec.com/ have agreed to jointly develop anti-inflammatory drugs.

http://www.sharewatch.com/story.php?storynumber=28257

Related Stories

No related posts.

Leave a Comment

You must be logged in to post a comment.

MATR Sponsor (view all)


The Missoula Chamber of Commerce advances the quality of life in Missoula by advocating for a healthy, responsible & diverse business environment & by providing resources that help businesses succeed. Contact Sharon Morren, Director of Membership, [email protected] to join.

MATR Supporters (view all)


We will bring the North Coast Hiawatha train route back to Southern Montana

ADROIT Employer Resources is a Montana-based workforce and talent solutions partner

Make Your Future in the College of Business